ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Survey Expected To Stimulate Surge Of Interest In Finding Etiological Factors In U .S. County-By-County Variations

April 19, 1974

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Clinical Trials Approved By NCI Last Month Are Listed

February 28, 2003

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

NCI’s caBIG to Expand For Clinical Informatics Projects.

January 26, 2007

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010